Gildea, L.; Ayariga, J.; Abugri, J.; Villafane, R. Phage Therapy: A Potential Novel Therapeutic Treatment of Methicillin-Resistant Staphylococcus aureus. Preprints2021, 2021110397. https://doi.org/10.20944/preprints202111.0397.v1
APA Style
Gildea, L., Ayariga, J., Abugri, J., & Villafane, R. (2021). Phage Therapy: A Potential Novel Therapeutic Treatment of Methicillin-Resistant <em>Staphylococcus aureus</em>. Preprints. https://doi.org/10.20944/preprints202111.0397.v1
Chicago/Turabian Style
Gildea, L., James Abugri and Robert Villafane. 2021 "Phage Therapy: A Potential Novel Therapeutic Treatment of Methicillin-Resistant <em>Staphylococcus aureus</em>" Preprints. https://doi.org/10.20944/preprints202111.0397.v1
Abstract
The emergence of multidrug-resistant bacterial strains, especially in the clinical setting, has renewed interest in alternative treatment methods. The utilization of prokaryotic viruses in phage therapy has demonstrated potential as a novel treatment method against multidrug-resistant bacterial infections. As the post-antibiotic era quickly approaches, the development and standardization of phage therapy is critically relevant to public health. This review serves to highlight the development of phage therapy against methicillin-resistant Staphylococcus aureus (MRSA), an antibiotic-resistant bacterial strain responsible for severe clinical infections.
Medicine and Pharmacology, Complementary and Alternative Medicine
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
